Autophagy Creates a CTL Epitope That Mimics Tumor-Associated Antigens

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Demachi Okamura, Ayako ^a   Torikai, Hiroki ^b   Akatsuka, Yoshiki ^a,c   Miyoshi, Hiroyuki ^d   Yoshimori, Tamotsu ^e   Kuzushima, Kiyotaka ^a,f  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d RIKEN BIORESOURCE CENTER   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; EPITOPE; PUROMYCIN SENSITIVE AMINOPEPTIDASE; UNCLASSIFIED DRUG;

ACIDIFICATION; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; ENDOSOME; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYSOSOME; NUCLEOTIDE SEQUENCE; POINT MUTATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA INTERFERENCE; UBIQUITINATION;

ACETYLCYSTEINE; AMINOPEPTIDASES; ANTIGENS, NEOPLASM; AUTOPHAGY; CELL LINE, TUMOR; EPITOPES; FIBROBLASTS; HLA-A24 ANTIGEN; HUMANS; LEUKEMIA; MOLECULAR MIMICRY; PANCREATIC NEOPLASMS; RECOMBINANT PROTEINS; RNA INTERFERENCE; T-LYMPHOCYTES, CYTOTOXIC; VACUOLES;

EID: 84867434740     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047126     Document Type: Article

References (48)

1. York IA, Rock KL, (1996) Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 14: 369-396.
2. Klionsky DJ, Emr SD, (2000) Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721.
3. Mathew R, Karantza-Wadsworth V, White E, (2007) Role of autophagy in cancer. Nat Rev Cancer 7: 961-967.
4. Deretic V, (2005) Autophagy in innate and adaptive immunity. Trends Immunol 26: 523-528.
5. Levine B, Deretic V, (2007) Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 7: 767-777.
6. Nimmerjahn F, Milosevic S, Behrends U, Jaffee EM, Pardoll DM, et al. (2003) Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur J Immunol 33: 1250-1259.
7. Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, et al. (2005) Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307: 593-596.
8. Butler MO, Lee JS, Ansen S, Neuberg D, Hodi FS, et al. (2007) Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell. Clin Cancer Res 13: 1857-1867.
9. Tian B, Pan Z, Lee JY, (2007) Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing. Genome Res 17: 156-165.
10. Kubo RT, Sette A, Grey HM, Appella E, Sakaguchi K, et al. (1994) Definition of specific peptide motifs for four major HLA-A alleles. Journal of immunology 152: 3913-3924.
11. Constam DB, Tobler AR, Rensing-Ehl A, Kemler I, Hersh LB, et al. (1995) Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization. J Biol Chem 270: 26931-26939.
12. Kondo E, Akatsuka Y, Kuzushima K, Tsujimura K, Asakura S, et al. (2004) Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles. Blood 103: 630-638.
13. English L, Chemali M, Duron J, Rondeau C, Laplante A, et al. (2009) Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 10: 480-487.
14. Kuzushima K, Hayashi N, Kimura H, Tsurumi T, (2001) Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood 98: 1872-1881.
15. Gromme M, Uytdehaag FG, Janssen H, Calafat J, van Binnendijk RS, et al. (1999) Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci U S A 96: 10326-10331.
16. Lizee G, Basha G, Tiong J, Julien JP, Tian M, et al. (2003) Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat Immunol 4: 1065-1073.
17. Vega MA, Strominger JL, (1989) Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. Proc Natl Acad Sci U S A 86: 2688-2692.
18. Lizee G, Basha G, Jefferies WA, (2005) Tails of wonder: endocytic-sorting motifs key for exogenous antigen presentation. Trends Immunol 26: 141-149.
19. van Weert AW, Geuze HJ, Groothuis B, Stoorvogel W, (2000) Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes. Eur J Cell Biol 79: 394-399.
20. Kimura S, Noda T, Yoshimori T, (2007) Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3: 452-460.
21. Mizushima N, Yoshimori T, Levine B, (2010) Methods in mammalian autophagy research. Cell 140: 313-326.
22. Schmid D, Munz C, (2007) Innate and adaptive immunity through autophagy. Immunity 27: 11-21.
23. Klionsky DJ, (2005) The molecular machinery of autophagy: unanswered questions. J Cell Sci 118: 7-18.
24. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, et al. (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131: 1149-1163.
25. Chen L, Uchida K, Endler A, Shibasaki F, (2007) Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation. J Biol Chem 282: 12707-12716.
26. Nagata Y, Hanagiri T, Takenoyama M, Fukuyama T, Mizukami M, et al. (2005) Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patient. Clin Cancer Res 11: 5265-5272.
27. Robbins PF, el-Gamil M, Li YF, Topalian SL, Rivoltini L, et al. (1995) Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J Immunol 154: 5944-5950.
28. Ogier-Denis E, Houri JJ, Bauvy C, Codogno P, (1996) Guanine nucleotide exchange on heterotrimeric Gi3 protein controls autophagic sequestration in HT-29 cells. J Biol Chem 271: 28593-28600.
29. Liang XH, Yu J, Brown K, Levine B, (2001) Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res 61: 3443-3449.
30. Proikas-Cezanne T, Waddell S, Gaugel A, Frickey T, Lupas A, et al. (2004) WIPI-1alpha (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagy. Oncogene 23: 9314-9325.
31. Susan PP, Dunn WA Jr, (2001) Starvation-induced lysosomal degradation of aldolase B requires glutamine 111 in a signal sequence for chaperone-mediated transport. J Cell Physiol 187: 48-58.
32. Ito H, Daido S, Kanzawa T, Kondo S, Kondo Y, (2005) Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. Int J Oncol 26: 1401-1410.
33. Fujii S, Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, et al. (2008) Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 99: 1813-1819.
34. Yang S, Wang X, Contino G, Liesa M, Sahin E, et al. (2011) Pancreatic cancers require autophagy for tumor growth. Genes Dev 25: 717-729.
35. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, et al. (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25: 460-470.
36. Kim MJ, Woo SJ, Yoon CH, Lee JS, An S, et al. (2011) Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation. J Biol Chem 286: 12924-12932.
37. Iguchi H, Morita R, Yasuda D, Takayanagi R, Ikeda Y, et al. (1994) Alterations of the p53 tumor-suppressor gene and ki-ras oncogene in human pancreatic cancer-derived cell-lines with different metastatic potential. Oncol Rep 1: 1223-1227.
38. Burrows SR, Rossjohn J, McCluskey J, (2006) Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol 27: 11-16.
39. Ebert LM, Liu YC, Clements CS, Robson NC, Jackson HM, et al. (2009) A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design. Cancer Res 69: 1046-1054.
40. Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, et al. (2005) T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol 6: 1114-1122.
41. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM, (1998) Development of a self-inactivating lentivirus vector. J Virol 72: 8150-8157.
42. Sugawara S, Abo T, Kumagai K, (1987) A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3. J Immunol Methods 100: 83-90.
43. Kuzushima K, Hoshino Y, Fujii K, Yokoyama N, Fujita M, et al. (1999) Rapid determination of Epstein-Barr virus-specific CD8(+) T-cell frequencies by flow cytometry. Blood 94: 3094-3100.
44. Torikai H, Akatsuka Y, Miyazaki M, Tsujimura A, Yatabe Y, et al. (2006) The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and-A*3303. Br J Haematol 134: 406-416.
45. Burdin N, Brossay L, Koezuka Y, Smiley ST, Grusby MJ, et al. (1998) Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J Immunol 161: 3271-3281.
46. Burgdorf S, Scholz C, Kautz A, Tampe R, Kurts C, (2008) Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 9: 558-566.
47. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR, (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59.
48. Tajima K, Demachi A, Ito Y, Nishida K, Akatsuka Y, et al. (2004) Identification of an epitope from the epithelial cell adhesion molecule eliciting HLA-A*2402-restricted cytotoxic T-lymphocyte responses. Tissue Antigens 64: 650-659.